MT1G and osteosarcoma: Metallothionein 1G (MT1G) regulates the cell’s antioxidant status and metal ion balance, influencing the proliferation and differentiation of MSCs, thereby affecting bone regeneration and repair processes, MT1G has been verified as a target for osteosarcoma (55).